These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 10469492

  • 21. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma.
    Srichairatanakool S, Thephinlap C, Phisalaphong C, Porter JB, Fucharoen S.
    Med Chem; 2007 Sep; 3(5):469-74. PubMed ID: 17897073
    [Abstract] [Full Text] [Related]

  • 22. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD.
    Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
    [Abstract] [Full Text] [Related]

  • 23. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
    Barton Pai A, Pai MP, Depczynski J, McQuade CR, Mercier RC.
    Am J Nephrol; 2006 Sep; 26(3):304-9. PubMed ID: 16809897
    [Abstract] [Full Text] [Related]

  • 24. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
    al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV.
    Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A novel method for non-transferrin-bound iron quantification by chelatable fluorescent beads based on flow cytometry.
    Ma Y, Podinovskaia M, Evans PJ, Emma G, Schaible UE, Porter J, Hider RC.
    Biochem J; 2014 Nov 01; 463(3):351-62. PubMed ID: 25093426
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron.
    Matinaho S, Karhumäki P, Parkkinen J.
    Transfusion; 2005 Nov 01; 45(11):1768-73. PubMed ID: 16271102
    [Abstract] [Full Text] [Related]

  • 30. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males.
    Schümann K, Kroll S, Romero-Abal ME, Georgiou NA, Marx JJ, Weiss G, Solomons NW.
    Ann Nutr Metab; 2012 Nov 01; 60(2):98-107. PubMed ID: 22398912
    [Abstract] [Full Text] [Related]

  • 31. Interaction of azotobactin with blocking and mobilizing agents in NTBI assay.
    Sharma M, Gohil NK.
    Mol Biosyst; 2010 Oct 01; 6(10):1941-6. PubMed ID: 20607173
    [Abstract] [Full Text] [Related]

  • 32. Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment.
    Gafter-Gvili A, Prokocimer M, Breuer W, Cabantchik IZ, Hershko C.
    Hematol J; 2004 Oct 01; 5(1):32-4. PubMed ID: 14745427
    [Abstract] [Full Text] [Related]

  • 33. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.
    Pootrakul P, Josephson B, Huebers HA, Finch CA.
    Blood; 1988 Apr 01; 71(4):1120-3. PubMed ID: 3355890
    [Abstract] [Full Text] [Related]

  • 34. A high-performance liquid immunoaffinity chromatography method for determining transferrin-bound iron in serum.
    Makino T, Nakamura K, Takahara K.
    Clin Chim Acta; 2011 May 12; 412(11-12):914-9. PubMed ID: 21256833
    [Abstract] [Full Text] [Related]

  • 35. Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats.
    Brissot P, Bolder U, Schteingart CD, Arnaud J, Hofmann AF.
    Hepatology; 1997 Jun 12; 25(6):1457-61. PubMed ID: 9185768
    [Abstract] [Full Text] [Related]

  • 36. Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.
    Garbowski MW, Ma Y, Fucharoen S, Srichairatanakool S, Hider R, Porter JB.
    Transl Res; 2016 Nov 12; 177():19-30.e5. PubMed ID: 27344508
    [Abstract] [Full Text] [Related]

  • 37. Non-transferrin bound iron: a key role in iron overload and iron toxicity.
    Brissot P, Ropert M, Le Lan C, Loréal O.
    Biochim Biophys Acta; 2012 Mar 12; 1820(3):403-10. PubMed ID: 21855608
    [Abstract] [Full Text] [Related]

  • 38. Automated assay for non-transferrin-bound iron in serum samples.
    Prezelj M, Knap B.
    Clin Chem Lab Med; 2010 Oct 12; 48(10):1427-32. PubMed ID: 20704529
    [Abstract] [Full Text] [Related]

  • 39. Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis.
    van Tits LJ, Jacobs EM, Swinkels DW, Lemmers HL, van der Vleuten GM, de Graaf J, Stalenhoef AF.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):371-6. PubMed ID: 16682004
    [Abstract] [Full Text] [Related]

  • 40. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation.
    Sahlstedt L, von Bonsdorff L, Ebeling F, Parkkinen J, Juvonen E, Ruutu T.
    Eur J Haematol; 2009 Nov 23; 83(5):455-9. PubMed ID: 19572995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.